The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1.
Torrisi
R
R
Pensa
F
F
Fontana
V
V
Costa
A
A
Decensi
A
A
D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D017313:Fenretinide / Q000494:pharmacology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000187:drug effects*; D008875:Middle Aged; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000097:blood
D017313:Fenretinide; D014212:Tretinoin; D007334:Insulin-Like Growth Factor I; C058346:N-(4-methoxyphenyl)retinamide